Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: Preliminary study

Neurology India

Volumn 54, Issue 4, 2006, Pages 390-393

  Shinde, Santosh ^a   Pasupathy, K ^b  

^a LTMGH ^*  (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Mitochondrial respiratory chain; Oxidative phosphorylation; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; LEVODOPA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; LYMPHOCYTE; MALE; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; RESPIRATORY CHAIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 33845332016     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.28112     Document Type: Article

References (25)

1. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-73.
2. Langston JN, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-80.
3. Chiva KA, Trevor A, Castagholi N Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 1984;120:574-8.
4. Jatvich JA, D'Amato RJ, Strittmater SM, Snyder SH. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Nati Aced Sci USA 1985;82:2173-7.
5. Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-1,2,3,6-tetrahydropyridine. Life Sci 1985;36:2503-8.
6. Lee CP, Martens ME. Mitochondrial respiration and energy metabolism in muscle. In: Engel AG, Bauber BQ, editors. Myology, Vol. 2. McGraw-Hill: New York; 1986. p. 643-71.
7. Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-23.
8. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, et al. Anatomic and disease specificity of NADH: CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142-5.
9. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989;163:1450-5.
10. Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD Jr, Turnbull DM. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci 1991;104:203-8.
11. Shoffner JM, Watts RL, Junces JL, Torrom A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991;30:332-9.
12. Reichmann H, Riederer P, Seufert S. Disturbances of the respiratory chain in brain from patients with Parkinson's disease [Abstract]. Movement Disord 1990;5:28.
13. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42.
14. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron transport system associated with the outer membrane of the mitochondria. J Cell Biol 1967;32:415-38.
15. Srere PA. Citrate synthase from hyperthermophilic Archaea. Methods Enzymol 2001;331:3-12.
16. King TE. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol 1967;10:322-31.
17. Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 1967;10:245-50.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1967;32:415-38.
19. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-7.
20. Nagatsu T, Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 1988;87:178-82.
21. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, et al. Basal lipid peroxidation in substantia nigra in Parkinson's disease. J Neurochem 1989;52:381-9.
22. Leehey M, Boyson SS. The biochemistry of Parkinson's disease. In: Appal SH, editor. Current neurology, Vol. 11. MO: Mosby Year Book: St. Louis; 1991. p. 233-6.
23. Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990;170:1044-8.
24. Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1992;4:27-34.
25. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira Al, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992;115:333-42.